Research ArticleArticle
Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report
Natalia V. Zamora, Robin Christensen, Niti Goel, Louise Klokker, Maria A. Lopez-Olivo, Lars E. Kristensen, Loreto Carmona, Vibeke Strand, Jeffrey R. Curtis and Maria E. Suarez-Almazor
The Journal of Rheumatology June 2017, jrheum.161108; DOI: https://doi.org/10.3899/jrheum.161108
Natalia V. Zamora
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Robin Christensen
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Niti Goel
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Louise Klokker
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Maria A. Lopez-Olivo
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Lars E. Kristensen
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Loreto Carmona
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Vibeke Strand
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Jeffrey R. Curtis
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Maria E. Suarez-Almazor
From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain. N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center. Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org. Accepted for publication March 22, 2017.
Article Information
jrheum.161108
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 15, 2017.
Article Versions
- You are currently viewing a Latest version of this article (June 15, 2017 - 04:02).
- View the most recent version of this article
Copyright & Usage
© 2017 The Journal of Rheumatology
Author Information
- Natalia V. Zamora,
- Robin Christensen,
- Niti Goel,
- Louise Klokker,
- Maria A. Lopez-Olivo,
- Lars E. Kristensen,
- Loreto Carmona,
- Vibeke Strand,
- Jeffrey R. Curtis and
- Maria E. Suarez-Almazor
- From the Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas; Advisory Services, Quintiles IMS; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Division of Immunology and Rheumatology, Stanford University, Palo Alto, California; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA; Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Instituto de Salud Musculoesqueletica, Madrid, Spain.
N.V. Zamora, MD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center, and Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; R. Christensen, MSc, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; N. Goel, MD, PhD, Advisory Services, Quintiles IMS, and Division of Rheumatology, Duke University School of Medicine; L. Klokker, PT, MSc, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital; M.A. Lopez-Olivo, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center; L.E. Kristensen, MD, PhD, Musculoskeletal Statistics Unit, The Parker Institute, Bispebjerg and Frederiksberg Hospital, L. Carmona, MD, PhD, Instituto de Salud Musculoesqueletica; V. Strand, MD, MACR, FACP, Division of Immunology and Rheumatology, Stanford University; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; M.E. Suarez-Almazor, MD, PhD, Section of Rheumatology and Clinical Immunology, University of Texas MD Anderson Cancer Center.
Address correspondence to Dr. M.E. Suarez-Almazor, 1515 Holcombe Blvd., Unit 1467, Houston, Texas 77030, USA. E-mail: msalmazor@mdanderson.org.
Accepted for publication March 22, 2017.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report
Natalia V. Zamora, Robin Christensen, Niti Goel, Louise Klokker, Maria A. Lopez-Olivo, Lars E. Kristensen, Loreto Carmona, Vibeke Strand, Jeffrey R. Curtis, Maria E. Suarez-Almazor
The Journal of Rheumatology Jun 2017, jrheum.161108; DOI: 10.3899/jrheum.161108
Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report
Natalia V. Zamora, Robin Christensen, Niti Goel, Louise Klokker, Maria A. Lopez-Olivo, Lars E. Kristensen, Loreto Carmona, Vibeke Strand, Jeffrey R. Curtis, Maria E. Suarez-Almazor
The Journal of Rheumatology Jun 2017, jrheum.161108; DOI: 10.3899/jrheum.161108